Investigating the Role of Oncotype DX in the Treatment of Early Stage Luminal A Breast

被引：0
|
作者：
Hughes, L. [1 ]
Mcveigh, T. [1 ]
Keane, M. [2 ]
Sweeney, K. [1 ]
Kerin, M. [1 ]
机构：
[1] Natl Univ Ireland Galway, Discipline Surg, Galway, Ireland
[2] Galway Univ Hosp, Dept Oncol, Galway, Ireland
来源：
BRITISH JOURNAL OF SURGERY | 2015年 / 102卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
1033
引用
收藏
页码：17 / 17
页数：1
相关论文
共 50 条
  • [1] THE ONCOLOGY NURSE'S ROLE IN THE ADJUVANT TREATMENT OF EARLY STAGE BREAST CANCER: STREAMLINING THE PROCESS OF ORDERING ONCOTYPE DX BREAST CANCER ASSAY
    Warnke, JoEllen
    Roberto, Kathleen
    ONCOLOGY NURSING FORUM, 2010, 37 (03) : E211 - E211
  • [2] Correlation of Oncotype Dx Recurrence Score and Luminal Subtypes of Breast Cancer
    Henderson, S.
    Xie, X-J
    Peng, Y.
    Euhus, D.
    Leitch, M.
    Rao, R.
    Haley, B.
    Sarode, V.
    CANCER RESEARCH, 2010, 70
  • [3] Racial Variation in the Uptake of Oncotype DX Testing for Early-Stage Breast Cancer
    Roberts, Megan C.
    Weinberger, Morris
    Dusetzina, Stacie B.
    Dinan, Michaela A.
    Reeder-Hayes, Katherine E.
    Carey, Lisa A.
    Troester, Melissa A.
    Wheeler, Stephanie B.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02) : 130 - +
  • [4] The effect of Oncotype DX® on adjuvant chemotherapy treatment decisions in early breast cancer
    Rabie, M. A.
    Rankin, A.
    Burger, A.
    Youssef, M. M. G.
    ANNALS OF THE ROYAL COLLEGE OF SURGEONS OF ENGLAND, 2019, 101 (08) : 596 - 601
  • [5] Oncotype DX® as a routine procedure to select adjuvant treatment in early breast cancer
    Gasol, A.
    Morales Murillo, S. M. M.
    Aguirre Ortega, E. A. O.
    Siso Raber, C. S. R.
    Panades Siurana, M. P. S.
    Vilardell Villellas, F. V. V.
    Canosa Morales, C. C. M.
    Gonzalez Falco, S. G. F.
    Iglesias Martinez, E. I. M.
    Salud Salvia, A. S. S.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S197 - S197
  • [6] Oncotype DX Breast Recurrence Score®: A Review of its Use in Early-Stage Breast Cancer
    Yahiya Y. Syed
    Molecular Diagnosis & Therapy, 2020, 24 : 621 - 632
  • [7] The Effect of Oncotype Dx® Recurrence Score on Treatment Recommendations for Patients with Early Stage Estrogen Receptor Positive Breast Cancer
    Acs, G.
    Esposito, N.
    Kiluk, J.
    Laronga, C.
    Lee, M. C.
    Loftus, L.
    Soliman, H.
    Boughey, J. C.
    Reynolds, C.
    Acs, P.
    Gordan, L.
    CANCER RESEARCH, 2009, 69 (24) : 726S - 726S
  • [8] Risk classification of Early Stage Breast Cancer as Assessed by MammaPrint and Oncotype DX Genomic Assays
    Clough, K. B.
    Poulet, B.
    Jamshidian, F.
    Butler, S.
    Svedman, C.
    Levy, E.
    CANCER RESEARCH, 2012, 72
  • [9] Cost effectiveness of oncotype Dx for early stage breast cancer; under National Health Insurance
    Kim, Y.
    Kim, K. E.
    Ju, Y. W.
    Lee, E.
    Lee, H. B.
    Moon, H. G.
    Noh, D. Y.
    Han, W.
    EUROPEAN JOURNAL OF CANCER, 2018, 92 : S31 - S31
  • [10] Cost effectiveness of oncotype Dx for early stage breast cancer under National health insurance
    Kim, Yumi
    Han, Wonshik
    CANCER RESEARCH, 2018, 78 (04)
12345